About Evidation
Evidation is a company based in Menlo Park (United States) founded in 2012 by Alessio Signorini. It operates as a Data-as-a-Service and Professional Services. Evidation has raised $259.16 million across 7 funding rounds from investors including McKesson, General Electric and Revelation Partners. Evidation offers products and services including Real-World Data Platform and Patient Insights. Evidation operates in a competitive market with competitors including myTomorrows, Antidote, Dyania Health, SubjectWell and Belong, among others.
- Total Equity Funding$259.16M (USD)
in 7 rounds
- Latest Funding Round$153M (USD), Series E
Mar 2021
- InvestorsMcKesson
& 13 more
Products & Services of Evidation
Evidation offers a comprehensive portfolio of products and services, including Real-World Data Platform and Patient Insights.
Real-world health data is collected for research purposes.
Patient experiences are analyzed for health outcome improvements.
Apps and channels of Evidation
its YouTube channel Evidation has 1.27K subscribers and 12 videos.
Videos from Evidation
The most watched videos on Evidation's YouTube channel, Evidation (1.27K subscribers). Click a video to play it here.
More on Evidation.
Funding Insights of Evidation
Evidation has successfully raised a total of $259.16M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $153 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $259.16M
- Total Rounds 7
- Last Round Series E — $153M
- Investors Count 14
All 7 funding rounds of Evidation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $153M | Series E | – | OMERS | |
| Jul 2020 | $45M | Series D | – | B Capital | |
| Aug 2018 | $30M | Series C | – | SV Health Investors, B Capital | |
| Apr 2017 | $10M | Series B | – | Sanofi Ventures | |
| Oct 2016 | $15M | Series B | – | B Capital | |
| Jan 2015 | $6.16M | Series A | – | General Electric, Rock Health | – |
| Jan 2012 | – | Seed | – | – |
14 investors in total: 13 institutional and 1 angel.
Investors in Evidation
Evidation has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include McKesson, General Electric and Revelation Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multistage investments are directed toward technology, healthcare, and climate sectors. | – | b.capital | Manhattan Beach, United States | |
Private equity investments are managed for municipal pension plans. | – | omersprivateequity.com | London, United Kingdom | |
Life sciences and tech focused impact VC firm funding companies in the US, the UK and Canada | – | rethinkimpact.com | Washington, Dc, United States | |
Venture capital fund focused on early-stage healthcare startups | – | svhealthinvestors.com | Boston, United States | |
Tech startups are funded by S32, a venture capital entity. | – | s32.com | Sunnyvale, United States | |
Life-Sciences focused Early stage Corporate VC Firm investing in the US | – | sanofiventures.com | Paris, France | |
VC firm focusing on life science sector | – | pappas-capital.com | Durham, United States | |
Investments are made by Fresco Capital in seed-stage startups. | – | fresco.vc | Earth, United States | |
Digital Health focused VC & Accelerator firm investing in the US | – | rockhealth.com | San Francisco, United States | |
Early-stage US companies are invested in by Asset Management Ventures. | – | assetman.com | Palo Alto, United States |
Investor details for Evidation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Evidation
45 people are tracked at Evidation (19 in leadership, 1 in board & advisors, 25 in team).
| Name | Role | Group |
|---|---|---|
Alessio Signorini | Co-Founder & CTO | Leadership |
Leslie Oley Wilberforce | CEO | Leadership |
Leslie Oley | Chief Operating Officer | Leadership |
Christine Lemke | Co-Founder & CEO | Leadership |
Raymond Cosey | Chief Financial Officer | Leadership |
Bertina Yen | VP, People & Operations | Leadership |
Meg Dryer | Chief Marketing & Design Officer | Leadership |
Laura Ditlevsen | Head Of Human Resources | Leadership |
Christian J. Cerrada | Director Of Health Behavior Research | Leadership |
Aslan Brooke | Sr. Director, Technology Infrstructure | Leadership |
Todd Stiles | Techops Director | Leadership |
Michael McClintock | VP Engineering, Platform | Leadership |
Maggie Sandoval | Vice President, Delivery | Leadership |
Abigail Levine | Senior Director, Product & Portfolio Strategy | Leadership |
Stephanie Jones | Senior Vice President Of Regulatory, Quality & Clinical | Leadership |
Susmita Kundu | Director Of Engineering | Leadership |
Phil Johnson | Chief Commercial Officer | Leadership |
Ernesto Ramirez | Senior Director, Research Science | Leadership |
Joyce H. N. Nortey | Senior Director, Clinical Research & Digital Health Initiatives | Leadership |
Deborah Kilpatrick | Executive Chair | Board & advisors |
25 more people are available in the full profile.
Complete people profiles for Evidation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Evidation
3 dated milestones of Evidation across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Evidation is founded.
- Funding First funding round.
- Funding Latest funding round, Series E, of $153.0M.
Competitors of Evidation
Evidation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as myTomorrows, Antidote, Dyania Health, SubjectWell and Belong, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mytomorrows.com | 2012 | Amsterdam, Netherlands | $22.3M | – | Platform provides access to drugs in development to patients and physicians | |
| antidote.me | 2008 | London, United Kingdom | $52M | 39 | Provider of search engine tool for patients to explore, understand and access clinical trials. | |
| dyaniahealth.com | 2019 | Sacramento, United States | $15.3M | – | Patients for clinical trials are identified through a dedicated platform. | |
| subjectwell.com | 2012 | Austin, United States | $46.8M | – | Clinical trials marketplace for patient recruitment solutions is provided. | |
| belong.co | 2014 | Bengaluru, India | $15M | 1 | AI-enabled platform sources candidates for inclusive employment of disabled individuals. | |
| clarahealth.com | 2015 | Boston, United States | $18.19M | 36 | Clinical trials are matched to patients via an online platform. | |
| jumohealth.com | 2009 | New Haven, United States | $12.53M | 3 | Jumo Health is focused on improving clinical trial patient experiences. | |
| trialbee.com | 2010 | Malmo, Sweden | $21.13M | – | Cloud-based clinical trial recruitment solutions are provided for pharmaceutical companies. |
Detailed competitors of Evidation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Evidation
The website of Evidation (evidation.com) receives about 933.2K visits a month and ranks #47,573 among all websites worldwide, #1,222 in Health.
- Monthly visits933.2K
▲ 4.1% vs previous month
- Unique visitors355K
per month
- Global rank#47,573
among all websites
- Category rank#1,222
Health · Health
- Bounce rate39%
- Pages per visit4.8
- Average visit2 min 42 sec
- DevicesDesktop 15% · Mobile 85%
Websites whose visitors overlap most with Evidation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| integrishealth.org | 100% | 269.2K | #199,876 | View details | |
| mobihealthnews.com | 100% | 133.6K | #351,855 | View details | |
| myfitnesspal.com | 66% | 11.7M | #5,180 | View details | |
unisom.com | unisom.com | 60% | – | #596,498 | – |
solgarvitamin.ru | solgarvitamin.ru | 60% | – | #218,329 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Evidation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Evidation
Complete news archive for Evidation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Evidation
10 companies that operate in the same segment as Evidation (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Evidation
Evidation was founded in 2012.
Evidation is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Leslie Oley Wilberforce is the current CEO of Evidation.
Evidation is a funded company, having raised a total of $259.16M across 7 funding rounds to date.
Evidation is focused on collecting and analyzing real-world health data to support faster decisions in healthcare. Services are offered to life sciences, government, non-profit organizations, and digital health sectors. Solutions include patient cohort recontact, continuous data generation, and insights into patient experiences to improve access and outcomes. The platform integrates electronic health records, patient-reported outcomes, and social determinants of health for comprehensive research.
Evidation's top competitors include myTomorrows, Dyania Health and SubjectWell.
Evidation offers Real-World Data Platform and Patient Insights.
Evidation has 14 investors. Key investors include McKesson, General Electric, Revelation Partners, B Capital, and OMERS Private Equity.
Evidation operates through Evidation Health, Inc..
The website of Evidation receives about 933 thousand visits a month and ranks #47,573 among all websites worldwide.